72 results
Page 3 of 4
10-Q
s7mmzr9z3k7kl0e
14 May 21
Quarterly report
4:31pm
10-K
EX-10.3
vdf202
31 Mar 21
Annual report
4:30pm
10-K
EX-10.2
sj0 f7t4u5
31 Mar 21
Annual report
4:30pm
10-K
EX-10.1
e7156wn0w 4tb8
31 Mar 21
Annual report
4:30pm
10-K
ny3kn0thg0
31 Mar 21
Annual report
4:30pm
10-K
EX-10.9
wh9y2e 9t
31 Mar 21
Annual report
4:30pm
10-K
EX-10.4
w35h5
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
ejcgo2x
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
EX-4.4
jgiy78cs7 kpb2s5dtw
29 Jan 21
Shelf registration
4:48pm
S-3
d3xli67
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.3
lv3re cqkyjp87cwyy6
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.1
4t2hid
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-99.2
90g2wk8xrocdokg
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-10.1
psxwe ioxwq9e0p9ka
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-10.1
c2fo6j qj4iish4lwxg9
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.1
9zlsyu rgvw
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
tybctwyg2o7m1x64e6o
2 Nov 20
Prospectus supplement
12:00am